Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Midatech Pharma ADR
(NQ:
MTP
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Mar 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Midatech Pharma ADR
< Previous
1
2
3
4
Next >
Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease
March 27, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's Intraday Session
March 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 24, 2023
Via
Benzinga
Midatech Pharma PLC Announces Results of General Meeting
March 24, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 22, 2023
Via
Benzinga
Midatech Pharma PLC Announces Further re: Notice of General Meeting
March 10, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting
March 08, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Result of General Meeting
January 23, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Planned Dose Escalation in MTX-110 Phase 1 Study
January 12, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 14, 2023
Via
Benzinga
Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 08, 2023
Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 08, 2023
Via
Benzinga
Midatech Pharma PLC Announces Posting of Circular and Notice of General Meeting
January 06, 2023
Via
ACCESSWIRE
Midatech Pharma PLC - First Patient Enrolled in Phase 1 Study of MTX-110
November 14, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
February 24, 2023
Via
Benzinga
Midatech Pharma PLC Announces Closing of $6.0m Private Placement & Broker Change
February 15, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Private Placement Raising US $6.0 million
February 09, 2023
Via
ACCESSWIRE
Midatech Pharma PLC Announces Receipt of NASDAQ Notice
February 03, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 19, 2023
Via
Benzinga
Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders
January 11, 2023
From
Bioasis Technologies Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 10, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Gainers
Via
Benzinga
Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc
December 19, 2022
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Midatech Pharma PLC Announces Closing of Offering, Revised Terms, AIM & Webinar
December 19, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 13, 2022
Via
Benzinga
Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc
December 13, 2022
US$10M Registered Direct Offering and PIPE to Strengthen Balance Sheet of Combined Company
From
Bioasis Technologies Inc.
Via
GlobeNewswire
Midatech Pharma PLC Announces Proposed Acquisition of Bioasis Technologies Inc
December 13, 2022
Via
ACCESSWIRE
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
Midatech Pharma PLC Announces Receipt of NASDAQ Notification
October 18, 2022
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.